LXEO filings
Corporate insider profile
Louis Edward Tamayo Filing Activity
Latest reported as Chief Financial Officer of Lexeo Therapeutics, Inc. (LXEO).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$41,040.62
- Latest transaction
- Aug 18, 2026
Affiliated corporations
Reported company relationships
Transaction history
